MedTrace Logo

The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands

NCT01080989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1477

Last updated 2017-05-09

No results posted yet for this study

Summary

The study project can be divided into two parts: (1) health screening for the community and (2) clinical diagnosis and treatment for patients at National Referral Hospital (NRH) in Solomon islands. The health screening includes a questionnaire, stool parasitic screening and blood laboratory tests. A total of 800 subjects will participate in this study. The collected samples are venous blood (20 ml/per subject) and stool in order to conduct the related tests mentioned above.

As for the collection of target patients, KMUH will cooperate with NRH to collect two kinds of blood samples: the blood samples of confirmed malarial cases and those of cases suspicious of Flaviviral, Alpha-viral, Rickettsial, and Leptospiral infections. The expected received cases are 600 each year. The venous blood samples (20 ml/per subject) will be used to conduct related tests mentioned above. At the same time, the subjects will also have to fill out a related questionnaire which includes height, weight, waist line, heath behavior and habit, and past history, etc.

Conditions

  • Flavivirus Infection
  • Alphavirus Infections
  • Malaria
  • Parasitic Disease
  • Leptospirosis
  • Hypertension
  • Metabolic Syndromes

Interventions

OTHER

diagnosis, treatment and education

Drug: anti-intestinal parasitic drugs: 1. mebendazole 500mg one dose (For Hook worm infections, Ascariasis, Trichuriasis) 2. albendazole(400 mg bid \* 7days) or Ivermectin(200 mcg/kg/day \* 2 days) (For Strongyloidiasis). Behavior: 1. Education capacity building (for local health personals): promote their ability of diagnosis and education to the community and patients for the associated diseases in this study. 2. Assist the trained local health personals to educate the patients and the community from the design of teaching materials and the contents.

Sponsors & Collaborators

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    lead OTHER

Principal Investigators

  • Sheng-Hsiung Sheu, Dr · Kaohsiung Medical University Chung-Ho Memorial Hospital

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Taiwan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01080989 on ClinicalTrials.gov